RT Journal Article
SR Electronic
A1 Hoyle, Brian
T1 Everolimus Safe and Effective for Advanced pNET: Final Results of RADIANT-3
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 36
SP 14
OP 16
DO 10.1177/155989771436011
UL http://mdc.sagepub.com/content/14/36/14.2.abstract
AB Final overall survival and safety results of the phase 3 Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor trial [RADIANT-3; NCT00412061] have bolstered previous findings that everolimus is effective and safe in the treatment of advanced pancreatic neuroendocrine tumors.